Maravai LifeSciences Holdings, Inc.

Thank you for standing by. I would like to welcome everyone to the Q2 2023 Mara Vai Life Sciences Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. I will now turn the conference over to Deborah Hart. Deb, please go ahead.

Good afternoon, everyone. Thanks for joining us on our second quarter 2023 earnings call. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com. As you can see on our agenda on slide two, joining me today are Trey Martin, our new CEO, Kevin Hrdy, Chief Financial Officer, and Carl Hull, Executive Chairman of the Board. Drew Burch, Executive Vice President and General Manager of our nucleic acid products, and Becky Buzio, our Chief Commercial Officer, will join the call for the question and answer session following the prepared remarks. We remind you, management will make forward-looking statements and refer to GAAP and non-GAAP financial measures during today's call. It's possible that actual results could differ from management's expectations. We refer you to slide three for more details on the forward-looking statements and our use of non-GAAP financial measures. Our just-issued press release provides reconciliations to the most directly comparable GAAP measures. Please also refer to Maravai's SEC filings for additional information on the risks and uncertainties that may impact our operating results, performance, and financial condition. Now I'll turn the call over to Carl.

Well, thank you, Deb, and good afternoon, everyone. We appreciate having you join us for our call today. During this call, we will provide the details of our financial results for the last quarter and our updated guidance. But first, I want to officially introduce and welcome Moravai's new CEO, Trey Martin, who took over his role on July 27th. As many of you know, Trey is a seasoned global life sciences executive with highly relevant industry experience from his time at IDT and Danner. He brings to Moravai an ideal mix of strategic, operational, and scientific acumen, combined with an outstanding operational track record. Over the course of his career, he has built and led complex global operations and successfully integrated multiple acquisitions, experiences particularly well aligned to lead the execution of Maravai's long-term strategic growth plan. I have already seen firsthand that Trey is an excellent cultural fit at Maravai. He is a results-oriented leader with the ability to guide and motivate teams within a culture of high integrity and high performance. I know he's the right CEO to take Maravai through its next phase of innovation and growth. Before I turn it over to Trey, I want to share with each of you the observation that leading Maravai has been the single most rewarding experience in my career. I could not be more proud of what we have accomplished together. I extend my sincere thanks to our leadership team and to the dedicated employees across the world who enthusiastically serve our customers and their communities every day. I'm excited about the company's future, where we are going, and what we can achieve together. I'm confident that we have the team, the talent, and the technology needed to deliver on our long-term objectives. If you'll turn to slide five, I'll now ask Trey to introduce himself and share some early observations. Over time, you'll have many other opportunities to get to know him better. Trey?